Subsequent large-cohort studies that have used these methods have demonstrated either no statistically significant reduction in breast cancer risk with RRSO (7) or a reduced risk in premenopausal BRCA2 mutation carriers only (8). The gene discussed is BRCA2; the disease is breast carcinoma.